Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults
Sponsor: Pfizer
Summary
The purpose of this study is to assess the bioequivalence of an alternative ODT formulation (ODT2) versus the approved ODT formulation of a CGRP receptor antagonist in healthy adult participants under fasting conditions.
Official title: A PHASE 1, OPEN LABEL, SINGLE DOSE, RANDOMIZED, CROSSOVER STUDY TO EVALUATE THE BIOEQUIVALENCE OF TWO FORMULATIONS OF A CGRP RECEPTOR ANTAGONIST IN HEALTHY ADULT PARTICIPANTS
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2026-05-18
Completion Date
2026-09-07
Last Updated
2026-05-22
Healthy Volunteers
Yes
Conditions
Interventions
ODT2 Test formulation
Test Formulation
ODT Reference formulation
Reference Formulation
Locations (1)
Pfizer Clinical Research Unit - Brussels
Brussels, Bruxelles-capitale, Région de, Belgium